Iyer, Gopa <br/><br/>
Multicenter Prospective Phase II Trial of Neoadjuvant Dose-Dense Gemcitabine Plus Cisplatin in Patients With Muscle-Invasive Bladder Cancer.  [electronic resource] 

 -  Journal of clinical oncology : official journal of the American Society of Clinical Oncology  07 2018 
 - 1949-1956 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1527-7755 
<br/><br/><label>Standard No.: </label>10.1200/JCO.2017.75.0158  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antineoplastic Combined Chemotherapy Protocols--adverse effects<br/>Chemotherapy, Adjuvant<br/>Cisplatin--administration & dosage<br/>Cystectomy<br/>Deoxycytidine--administration & dosage<br/>Disease-Free Survival<br/>Female<br/>Filgrastim--administration & dosage<br/>Humans<br/>Male<br/>Middle Aged<br/>Neoadjuvant Therapy<br/>Neoplasm Invasiveness<br/>Neoplasm Recurrence, Local--diagnostic imaging<br/>Neoplasm Staging<br/>Polyethylene Glycols--administration & dosage<br/>Prospective Studies<br/>Urinary Bladder Neoplasms--diagnostic imaging<br/>Gemcitabine